Karl Koster, Executive Director, Office of Corporate Relations
Hear from distinguished MIT faculty and startups on topics such as recent advances in precision medicine for a more targeted and personalized treatment, immunotherapy to fight cancer cells, gene therapy, AI to improve diagnosis, treatment, and patient outcomes, and more.
Joshua Feast, CEO & Cofounder, Cogito
P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Investing in the Drivers of the Future of Energy, Ben Sampson, Director, Energy, GE Ventures
Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
Synthetic Biology Workshop 2017 - Panel Discussion
Dilip Sundaram - Corporate Keynote
Andrew A. Radin & Andrew M. Radin
PathAI is evolving pathology using machine learning and deep learning techniques to drive faster more accurate diagnosis of disease.